Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors
Top Cited Papers
- 30 April 2013
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 34 (13), 3489-3502
- https://doi.org/10.1016/j.biomaterials.2013.01.077
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute's (NCI's) Alliance for Nanotechnology in Cancer
- Center for Cancer Nanotechnology Excellence (CCNE) (U54-CA151881)
- Cancer Nanotechnology Platform Partnership (CNPP) (U01-CA151452)
This publication has 41 references indexed in Scilit:
- ‘Click’ synthesis of dextran macrostructures for combinatorial-designed self-assembled nanoparticles encapsulating diverse anticancer therapeuticsBioorganic & Medicinal Chemistry, 2011
- Tumor vasculature is a key determinant for the efficiency of nanoparticle-mediated siRNA deliveryGene Therapy, 2011
- Definition of Ubiquitination Modulator COP1 as a Novel Therapeutic Target in Human Hepatocellular CarcinomaCancer Research, 2010
- Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in miceJCI Insight, 2009
- Mouse xenograft models vs GEM models for human cancer therapeuticsDisease Models & Mechanisms, 2008
- Evaluation of the effect of vector architecture on DNA condensation and gene transfer efficiencyJournal of Controlled Release, 2008
- Anticancer Therapeutics: Targeting Macromolecules and Nanocarriers to Hyaluronan or CD44, a Hyaluronan ReceptorMolecular Pharmaceutics, 2008
- Metastasis: a therapeutic target for cancerNature Clinical Practice Oncology, 2008
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinomaProceedings of the National Academy of Sciences of the United States of America, 2007